Research Subject Information
CHANGE OF ADDRESS - IntegReview IRB's address has changed effective July 6, 2015. Click here to access the Subject Memo regarding the change of address.
As an Institutional Review Board (IRB), IntegReview’s responsibility is to assure the protection of the rights and welfare of the research participants.
As a research participant, IntegReview IRB recommends that you ask and ensure you have answers to the following questions before deciding to participate in a research study:
- What is the main purpose of the study?
- Does the study involve a placebo (inactive treatment, equivalent to a sugar pill) or a treatment/device that is already on the market?
- How will the study drug/device be given to me?
- How long is the study going to last and what will I be asked to do as a participant?
- What has been learned about the study drug/device and are any study results published?
- Do I have to pay for any part of the study? Will my insurance cover these costs?
- Will I be able to see my own doctor?
- If the study drug/device works for me, can I keep using it after the study?
- Can anyone find out whether I’m participating in the research study?
- Will I receive any follow-up care after the study has ended?
- What will happen to my medical care if I stop participating in the study?
- Am I comfortable with the doctor and study staff as they will be medical care providers during the study?
Helpful Links for research participants
You may obtain answers to questions regarding your rights as a research subject by dialing our main office number at (512) 326-3001 or express concerns via e-mail to firstname.lastname@example.org.